Published in Biochem Biophys Res Commun on January 26, 1996
The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases. Front Pharmacol (2012) 1.37
Increased blood carboxyhaemoglobin concentrations in inflammatory pulmonary diseases. Thorax (2002) 1.02
Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study. Cell Stress Chaperones (2003) 0.96
Increased carbon monoxide in exhaled air of patients with cystic fibrosis. Thorax (1999) 0.94
Exhaled carbon monoxide in asthmatics: a meta-analysis. Respir Res (2010) 0.85
Disrupted postnatal lung development in heme oxygenase-1 deficient mice. Respir Res (2010) 0.83
Brain Iron Metabolism Dysfunction in Parkinson's Disease. Mol Neurobiol (2016) 0.77
Is glial heme oxygenase-1 suppression in neurodegenerative disorders permissive for neural repair? Neural Regen Res (2015) 0.75
Higher hydrocortisone dose increases bilirubin in hypopituitary patients- results from an RCT. Eur J Clin Invest (2016) 0.75
Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci U S A (2001) 2.21
Suppression of bilirubin production in the Crigler-Najjar type I syndrome: studies with the heme oxygenase inhibitor tin-mesoporphyrin. Pediatrics (1992) 2.14
Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc Natl Acad Sci U S A (1981) 2.04
Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood (2001) 1.88
Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci U S A (1994) 1.85
Heme oxygenase-1 protects against radiocontrast-induced acute kidney injury by regulating anti-apoptotic proteins. Kidney Int (2007) 1.80
Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia (2005) 1.69
Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science (1989) 1.67
Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension (2001) 1.48
Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin. Pediatrics (1998) 1.44
Arachidonic acid-induced endothelial-dependent relaxations of canine coronary arteries: contribution of a cytochrome P-450-dependent pathway. J Pharmacol Exp Ther (1987) 1.40
Chemoprevention of neonatal jaundice: potency of tin-protoporphyrin in an animal model. Science (1982) 1.36
Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem (1998) 1.35
Control of heme oxygenase and plasma levels of bilirubin by a synthetic heme analogue, tin-protoporphyrin. Hepatology (1984) 1.26
Tissue distribution and disposition of tin-protoporphyrin, a potent competitive inhibitor of heme oxygenase. J Pharmacol Exp Ther (1984) 1.24
Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc Soc Exp Biol Med (1997) 1.24
Control of heme metabolism with synthetic metalloporphyrins. J Clin Invest (1986) 1.23
Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest (2001) 1.21
Promotive effects of a silk film on epidermal recovery from full-thickness skin wounds. Proc Soc Exp Biol Med (2000) 1.20
A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension (1995) 1.19
Heme metabolism and in vitro erythropoiesis in anemia associated with hypochromic microcytosis. Am J Hematol (1988) 1.19
Erythroid 5-aminolevulinate synthase is located on the X chromosome. Am J Hum Genet (1990) 1.17
Tin-protoporphyrin suppression of hyperbilirubinemia in mutant mice with severe hemolytic anemia. Blood (1983) 1.15
Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolism. Arch Biochem Biophys (1987) 1.14
Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment. Blood (1993) 1.13
Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest (1990) 1.11
12(R)-hydroxyicosatetraenoic acid: a cytochrome-P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea. Proc Natl Acad Sci U S A (1987) 1.11
Presence of cytochrome P-450-dependent monooxygenase in intimal cells of the hog aorta. Hypertension (1986) 1.09
Manganese and zinc blockade of enzyme induction: studies with microsomal heme oxygenase. Proc Natl Acad Sci U S A (1979) 1.09
Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics (1999) 1.09
Impact of silencing HO-2 on EC-SOD and the mitochondrial signaling pathway. J Cell Biochem (2007) 1.08
Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR. Am J Physiol (1992) 1.08
Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics (1988) 1.07
Overexpression of the heme oxygenase gene in renal cell carcinoma. Proc Soc Exp Biol Med (1997) 1.07
Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns. Pediatrics (1995) 1.07
Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J Pharmacol Exp Ther (1999) 1.07
An experimental model of postnatal jaundice in the suckling rat. Suppression of induced hyperbilirubinemia by Sn-protoporphyrin. J Clin Invest (1984) 1.06
Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia. Inhibition of heme oxidation and bilirubin production. J Clin Invest (1985) 1.05
Heme oxygenase isoform-specific expression and distribution in the rat kidney. Kidney Int (2001) 1.05
Suppression of hyperbilirubinemia in the rat neonate by chromium-protoporphyrin. Interactions of metalloporphyrins with microsomal heme oxygenase of human spleen. J Exp Med (1982) 1.05
Presence of heme oxygenase and NADPH cytochrome P-450 (c) reductase in human corneal epithelium. Invest Ophthalmol Vis Sci (1987) 1.04
The cytochrome P-450-depleted animal: an experimental model for in vivo studies in chemical biology. Proc Natl Acad Sci U S A (1982) 1.03
The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin. Proc Natl Acad Sci U S A (1985) 1.03
Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat. Nephron (1996) 1.03
Heme oxygenase induction with attenuation of experimentally induced corneal inflammation. Biochem Pharmacol (1997) 1.02
Zinc porphyrins: potent inhibitors of hematopoieses in animal and human bone marrow. Proc Natl Acad Sci U S A (1997) 1.02
Cytochrome P-450-dependent monooxygenase activity and endothelial-dependent relaxations induced by arachidonic acid. J Pharmacol Exp Ther (1986) 1.01
Porphyrogenic effects and induction of heme oxygenase in vivo by delta-aminolevulinic acid. Biochim Biophys Acta (1981) 1.00
Carbon monoxide produced by isolated arterioles attenuates pressure-induced vasoconstriction. Am J Physiol Heart Circ Physiol (2001) 0.99
Heme oxygenase: a target gene for anti-diabetic and obesity. Curr Pharm Des (2008) 0.98
Heme oxygenase-1 transduction in endothelial cells causes downregulation of monocyte chemoattractant protein-1 and of genes involved in inflammation and growth. Cell Mol Biol (Noisy-le-grand) (2005) 0.98
Regulation of arachidonic acid metabolism by cytochrome P-450 in rabbit kidney. Biochem J (1986) 0.96
Metal ion interactions in the control of haem oxygenase induction in liver and kidney. Biochem J (1980) 0.96
Control of heme and cytochrome P-450 metabolism by inorganic metals, organometals and synthetic metalloporphyrins. Environ Health Perspect (1984) 0.96
Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am J Physiol (1999) 0.95
Heme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine. Proc Natl Acad Sci U S A (1991) 0.95
Cytochrome P450-dependent arachidonic acid metabolism in human kidney. Kidney Int (1990) 0.95
Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics (1994) 0.94
Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau. J Biol Chem (2000) 0.94
A closed eye contact lens model of corneal inflammation. Part 2: Inhibition of cytochrome P450 arachidonic acid metabolism alleviates inflammatory sequelae. Invest Ophthalmol Vis Sci (1995) 0.94
The role of NF-kappaB in the angiogenic response of coronary microvessel endothelial cells. Proc Natl Acad Sci U S A (1996) 0.92
Heme oxygenase-1 gene expression increases vascular relaxation and decreases inducible nitric oxide synthase in diabetic rats. Cell Mol Biol (Noisy-le-grand) (2005) 0.92
Hemin and L-arginine regulation of blood pressure in spontaneous hypertensive rats. J Am Soc Nephrol (1991) 0.92
Fluorometric measurement of tin-protoporphyrin in biological samples. Anal Biochem (1984) 0.91
Metal induction of haem oxygenase without concurrent degradation of cytochrome P-450. Protective effects of compound SKF 525A on the haem protein. Biochem J (1982) 0.91
Vasoregulatory function of the heme-heme oxygenase-carbon monoxide system. Am J Hypertens (2001) 0.90
Hemin stimulation of hemopoiesis in murine long-term bone marrow culture. Exp Hematol (1991) 0.90
Mechanisms of differentiation of U937 leukemic cells induced by GM-CSF and 1,25(OH)2 vitamin D3. Leuk Res (1991) 0.90
Prolonged induction of hepatic haem oxygenase and decreases in cytochrome P-450 content by organotin compounds. Biochem J (1980) 0.90
Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance. J Neurosci Res (2002) 0.89
Purification and properties of potato -1,4-glucan. -1,4-Glucan 6-glycosyltransferase (Q-enzyme). Eur J Biochem (1972) 0.89
Disposition of tin-protoporphyrin and suppression of hyperbilirubinemia in humans. Clin Pharmacol Ther (1986) 0.89
Tin-mediated heme oxygenase gene activation and cytochrome P450 arachidonate hydroxylase inhibition in spontaneously hypertensive rats. Am J Med Sci (1994) 0.89
Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin. Hepatology (1989) 0.89
Inhibition of human immunodeficiency virus-1 reverse transcriptase by heme and synthetic heme analogs. Proc Assoc Am Physicians (1996) 0.89
Heme-induced cell adhesion in the pathogenesis of sickle-cell disease and inflammation. Trends Pharmacol Sci (2001) 0.88
Identification of heme oxygenase and cytochrome P-450 in the rabbit heart. J Mol Cell Cardiol (1987) 0.87
Induction of heme oxygenase-1 in renovascular hypertension is associated with inhibition of apoptosis. Cell Mol Biol (Noisy-le-grand) (2007) 0.87
Negative regulation of human heme oxygenase in microvessel endothelial cells by dexamethasone. Proc Soc Exp Biol Med (1999) 0.87
Regulation of heme oxygenase gene expression by cobalt in rat liver and kidney. Eur J Biochem (1990) 0.87
A closed eye contact lens model of corneal inflammation. Part 1: Increased synthesis of cytochrome P450 arachidonic acid metabolites. Invest Ophthalmol Vis Sci (1995) 0.87
Dual role of heme oxygenase in epithelial cell injury: contrasting effects of short-term and long-term exposure to oxidant stress. J Lab Clin Med (1996) 0.86
12(R)-hydroxyeicosatrienoic acid: a vasodilator cytochrome P-450-dependent arachidonate metabolite from the bovine corneal epithelium. J Biol Chem (1988) 0.86
Purification and characterization of cytochrome P-450-dependent arachidonic acid epoxygenase from human liver. J Biol Chem (1988) 0.86
Properties of human kidney heme oxygenase: inhibition by synthetic heme analogues and metalloporphyrins. Biochem Biophys Res Commun (1988) 0.86
Heme oxygenase-1 expression levels are cell cycle dependent. Biochem Biophys Res Commun (2003) 0.86
Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Am J Physiol (1992) 0.86
Thyroid hormone regulation of heme oxidation in the liver. Proc Natl Acad Sci U S A (1982) 0.86
Upregulation of human heme oxygenase gene expression by Ets-family proteins. J Cell Biochem (1999) 0.86
Direct stimulation of limbal microvessel endothelial cell proliferation and capillary formation in vitro by a corneal-derived eicosanoid. Am J Pathol (1996) 0.85
Differential induction of heme oxygenase in the hepatocarcinoma cell line (Hep3B) by environmental agents. J Cell Biochem (1992) 0.85
Prolonged clinical use of a heme oxygenase inhibitor: hematological evidence for an inducible but reversible iron-deficiency state. Pediatrics (1993) 0.85
Long-term administration of massive doses of Sn-protoporphyrin in anemic mutant mice (sphha/sphha). J Exp Med (1985) 0.85
Elevated levels of heme oxygenase-1 activity and mRNA in peripheral blood adherent cells of acquired immunodeficiency syndrome patients. Am J Hematol (1993) 0.84
Cytochrome P450 dependent metabolism of arachidonic acid in bovine corneal epithelium. Biochem Biophys Res Commun (1985) 0.84
Renal cytochrome P-450-dependent metabolism of arachidonic acid in spontaneously hypertensive rats. Biochem Pharmacol (1988) 0.84
Novel regulatory sites of the human heme oxygenase-1 promoter region. Biochem Biophys Res Commun (1993) 0.84
N-acetylation of drugs. Pharmacogenetic studies in rabbits selected for their acetylator characteristics. Drug Metab Dispos (1976) 0.84
Potent heme-degrading action of antimony and antimony-containing parasiticidal agents. J Exp Med (1981) 0.84